Ms. Priyanka Shah O'brien, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1801 1st Ave Ste 3a, Longview, WA 98632 Phone: 360-636-4469 |
Edward Leon Treyve, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1801 1st Ave, Suite 3a, Longview, WA 98632 Phone: 360-636-4469 Fax: 360-425-4970 |
Jeffrey Rich Davis, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1801 1st Ave, Suite 3a, Longview, WA 98632 Phone: 360-636-4469 Fax: 360-425-4970 |
News Archive
Some hospitals are using a "customer management system" to "market to patients and physicians the same way supermarkets do - by sending information they think a customer needs or wants based on their history," American Medical News reports. "The use of CRM software by the health industry is aided by the increasing automation of data ranging from physician referrals to electronic medical records.
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, signed an agreement for the purchase of a Renaissance system with Richard R. M. Francis, MD, of Spine Associates of Houston and the Houston Orthopedic and Spine Hospital, formerly known as Foundation Surgical Hospital, in Bellaire, Texas.
WellPoint, the parent company of Anthem Blue Cross, has canceled an investor meeting "so that executives can prepare for a congressional hearing on the company's large rate hikes in California," the Los Angeles Times reports. "A subcommittee of the House Committee on Energy and Commerce has called WellPoint Inc. Chief Executive Angela F. Braly to testify Feb. 24 about planned premium increases of as much as 39% for many of Anthem's 800,000 individual policyholders in California."
Motivating willingness to change is important in treating a person with severe worry. For this, integrating motivational interviewing (MI) techniques into the commonly practised cognitive behavioral therapy (CBT) is the ideal option, a study led by a York University researcher reveals.
Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T-cell therapies to treat cancer, announced today that the companies have extended their non-exclusive research alliance.
› Verified 6 days ago